Literature DB >> 23589194

Cytomegalovirus and multiple sclerosis risk.

Julia Pakpoor, Jina Pakpoor, Giulio Disanto, Gavin Giovannoni, Sreeram V Ramagopalan.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23589194     DOI： 10.1007/s00415-013-6912-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  17 in total

1.  Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis.

Authors:  Nima Sanadgol; Nourollah Ramroodi; Ghasem Ali Ahmadi; Majid Komijani; Ali Moghtaderi; Majid Bouzari; Marzieh Rezaei; Mohammad Taghi Kardi; Soroush Dabiri; Malek Moradi; Ehsan Sanadgol
Journal:  New Microbiol       Date:  2011-07-30       Impact factor: 2.479

2.  Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients.

Authors:  Robert Zivadinov; Davide Nasuelli; Maria Antonietta Tommasi; Maurizia Serafin; Alessio Bratina; Maja Ukmar; Istvan Pirko; Aaron J Johnson; Christina Furlan; Roberto S Pozzi-Mucelli; Luisa Monti-Bragadin; Attilio Grop; Massimo Zambon; Rodolfo M Antonello; Giuseppe Cazzato; Marino Zorzon
Journal:  Neurol Res       Date:  2006-04       Impact factor: 2.448

3.  Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.

Authors:  K M Myhr; T Riise; E Barrett-Connor; H Myrmel; C Vedeler; M Grønning; M B Kalvenes; H Nyland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

4.  Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

Authors:  K Wandinger; W Jabs; A Siekhaus; S Bubel; P Trillenberg; H Wagner; K Wessel; H Kirchner; H Hennig
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

5.  Epstein-Barr virus and disease activity in multiple sclerosis.

Authors:  D Buljevac; G J J van Doornum; H Z Flach; J Groen; A D M E Osterhaus; W Hop; P A van Doorn; F G A van der Meché; R Q Hintzen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

6.  Viral and bacterial antibody responses in multiple sclerosis.

Authors:  F Vartdal; B Vandvik; E Norrby
Journal:  Ann Neurol       Date:  1980-09       Impact factor: 10.422

7.  Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets.

Authors:  L Provinciali; M A Laurenzi; L Vesprini; A R Giovagnoli; C Bartocci; M Montroni; P Bagnarelli; M Clementi; P E Varaldo
Journal:  Acta Neurol Scand       Date:  1988-12       Impact factor: 3.209

8.  Association of Epstein-Barr virus infection with multiple sclerosis in India.

Authors:  Lekha Pandit; Chaitra Malli; Anita D'Cunha; Rajesh Shetty; Bhim Singhal
Journal:  J Neurol Sci       Date:  2013-01-09       Impact factor: 3.181

9.  Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.

Authors:  P Höllsberg; H J Hansen; S Haahr
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

10.  Multiple sclerosis in Galion, Ohio: prevalence and results of a case-control study.

Authors:  R S Hopkins; R W Indian; E Pinnow; J Conomy
Journal:  Neuroepidemiology       Date:  1991       Impact factor: 3.282
View more
  6 in total

1.  Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.

Authors:  Annette Langer-Gould; Jun Wu; Robyn Lucas; Jessica Smith; Edlin Gonzales; Lilyana Amezcua; Samantha Haraszti; Lie Hong Chen; Hong Quach; Judith A James; Lisa F Barcellos; Anny H Xiang
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

2.  Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice.

Authors:  Jelena Milovanovic; Branka Popovic; Marija Milovanovic; Daria Kvestak; Aleksandar Arsenijevic; Bojana Stojanovic; Irena Tanaskovic; Astrid Krmpotic; Nebojsa Arsenijevic; Stipan Jonjic; Miodrag L Lukic
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

Review 3.  Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.

Authors:  A-F A Mentis; E Dardiotis; N Grigoriadis; E Petinaki; G M Hadjigeorgiou
Journal:  Acta Neurol Scand       Date:  2017-05-23       Impact factor: 3.209

4.  Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment.

Authors:  Linn Persson Berg; Marcus Eriksson; Sonia Longhi; Ingrid Kockum; Clemens Warnke; Elisabeth Thomsson; Malin Bäckström; Tomas Olsson; Anna Fogdell-Hahn; Tomas Bergström
Journal:  BMJ Neurol Open       Date:  2022-07-27

5.  Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation.

Authors:  Marjan Vanheusden; Bieke Broux; Suzanne P M Welten; Liesbet M Peeters; Eleni Panagioti; Bart Van Wijmeersch; Veerle Somers; Piet Stinissen; Ramon Arens; Niels Hellings
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

Review 6.  Role of Viruses in the Pathogenesis of Multiple Sclerosis.

Authors:  Rachael E Tarlinton; Ekaterina Martynova; Albert A Rizvanov; Svetlana Khaiboullina; Subhash Verma
Journal:  Viruses       Date:  2020-06-13       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.